Evidence map›Paper›PMID 18411320›Full record

ArticleAntimicrobial agents and chemotherapy2008

Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin.

Kyriaki Kanellakopoulou, George C Thivaios, Maria Kolia, Ismini Dontas, Lydia Nakopoulou, Eleftherios Dounis, Evangelos J Giamarellos-Bourboulis, Andreas Andreopoulos, Panayotis Karagiannakos, Helen Giamarellou

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. [Comparative study of different concentrations of methicillin-resistantZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2018
    Article
  3. Silver nanoparticle deposited implants to treat osteomyelitis.Journal of biomedical materials research. Part B, Applied biomaterials · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Kyriaki Kanellakopoulou4th Department of Internal Medicine, Attikon University Hospital, 1 Rimini Str., Athens 124 62, Greece. kyrkanel@yahoo.gr
George C Thivaios
Maria Kolia
Ismini Dontas
Lydia Nakopoulou
Eleftherios Dounis
Evangelos J Giamarellos-Bourboulis
Andreas Andreopoulos
Panayotis Karagiannakos
Helen Giamarellou
Athens State University · USLaiko General Hospital of Athens · GRNational and Kapodistrian University of Athens · GRNational Polytechnic School · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A biodegradable system of poly-D,L-dilactide releasing ciprofloxacin was assessed in a Pseudomonas aeruginosa osteomyelitis model after inoculation of the test pathogen into the left tibia of 76 New Zealand White rabbits; 31 were controls (group A), and 45 were implanted with the polymer at the infection site (group B). The rabbits were killed on a weekly basis, and cancellous bone was harvested for histopathology and for estimation of bacterial growth and the concentrations of ciprofloxacin. Tibial X ray was performed immediately before the animals were killed. The total number of fistulas with purulent discharge that developed after inoculation of the pathogen was counted, and fistulas with purulent discharge were found in 16 animals in group A (51.6%) and 3 animals in group B (6.7%) (P < 0.0001). The animals in group A had a profound loss of body weight compared to the animals in group B. The main radiological finding was the presence of sequestra in 25 animals (80.6%) in group A and 6 animals in group B (13.3%) (P < 0.0001). The bacterial load in group B was significantly reduced compared to that in group A, possibly due to the prolonged local antibiotic release at concentrations exceeding even 80 times the MIC for the test pathogen. The histology of animals killed after week 49 revealed a mild inflammatory reaction accompanied by diffuse fibrosis and new bone formation in group A animals and the presence of small polymer particles in group B animals. It is concluded that the system described achieved eradication of the pathogen, accompanied by clinical and radiologically confirmed benefits, so this treatment may be a candidate for the management of difficult orthopedic infections.

Indexed as

Absorbable ImplantsAnimalsAnti-Bacterial AgentsCiprofloxacinDisease Models, AnimalDrug ImplantsHumansMaleOsteomyelitisPolyestersPseudomonas aeruginosaPseudomonas InfectionsRabbitsTibiaAnti-Bacterial AgentsCiprofloxacinDrug ImplantsPolyesterspoly(lactide)

Identifiers

PMID18411320
PMCPMC2443917
OpenAlexW2118603595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.